Measure Twice, Cut Once: Commercial Pre-Litigation Assessments for Life Sciences Companies

We invite you to join Arnold & Porter partners Samuel Lonergan, Carmela Romeo, and Jeff Fuisz, as they discuss the risks and benefits for publicly traded pharmaceutical, biotechnology, medical device, and health care product and service companies considering litigation. From risk mitigation to cost savings, a pre-litigation assessment can play a crucial role for life sciences companies facing commercial disputes and a thicket of regulatory scrutiny.

This one-hour webinar will provide in-house counsel and executives critical considerations, best practices, common issues, and case studies of litigation involving life sciences companies.